NeuroMetrix, Inc. develops and commercializes non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company provides the Quell product line, which includes wearable neurostimulator devices designed to relieve symptoms of fibromyalgia and other conditions. The Quell device is a thin, wearable medical device that uses nerve stimulation, features a custom-designed microchip for flexible and precise stimulation, and utilizes position and motion sensing to automatically adjust therapy. The system supports Bluetooth Low Energy to communicate with the Quell Fibromyalgia app, enabling users to personalize therapy, track utilization, sleep, and fibromyalgia severity on iOS and Android devices. The company was founded in 1996 and is based in Woburn, Massachusetts.
Metrics to compare | NURO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNUROPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −2.8x | −0.6x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 0.0x | 3.6x | 2.6x | |
Price / LTM Sales | 0.0x | 2.6x | 3.4x | |
Upside (Analyst Target) | 0.0% | 71.6% | 41.5% | |
Fair Value Upside | Unlock | 15.9% | 5.5% | Unlock |